ARCA Biopharma Inc (NASDAQ:ABIO)
| 2.83 Delayed Data As of Sep 30 |  -0.02 / -0.70%Today’s Change | 2.73 Today|||52-Week Range 6.97 | -39.14% Year-to-Date |
Latest ABIO News | Press Releases
No recent news for ARCA Biopharma Inc.
Today’s Trading
| Previous close | 2.85 |
| Today’s open | 2.86 |
| Day’s range | 2.81 - 2.90 |
| Volume | 8,518 |
| Average volume (3 months) | 18,082 |
| Market cap | $25.8M |
| Dividend yield | -- |
Data as of 3:59pm ET, 09/30/2016
Growth & Valuation
| Earnings growth (last year) | +44.68% |
| Earnings growth (this year) | +28.57% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.68 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| APRIApricus Biosciences ... | +0.00 | +0.68% |
| IMNPImmune Pharmaceutica... | +0.02 | +8.80% |
| BIODBiodel Inc | +0.02 | +4.10% |
| SBOTStellar Biotechnolog... | -0.05 | -2.04% |
Data as of 3:59pm ET, 09/30/2016
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$11.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Michael R. Bristow |
Chief Operating Officer Thomas A. Keuer |
Corporate headquarters Westminster, Colorado |
Forecasts
